Related Experiment Video
Updated: Sep 16, 2025

10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
14.5K
Non-coding RNAs in alcohol-associated liver disease.
Ge Zeng1,2, Hui Gao2, Yanchao Jiang2
1Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Liver Research (Beijing, China)
|July 7, 2025
Summary
Non-coding RNAs (ncRNAs) are crucial in alcohol-associated liver disease (ALD). Dysregulated ncRNAs drive liver injury, inflammation, and fibrosis, offering potential as biomarkers and therapeutic targets for ALD.
Area of Science:
- Molecular Biology
- Hepatology
- Genetics
Background:
- Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), regulate gene expression.
- Chronic alcohol consumption significantly impacts ncRNA expression and function in the liver and circulation.
- Dysregulated ncRNAs are implicated in the pathogenesis of alcohol-associated liver disease (ALD).
Purpose of the Study:
- To provide a comprehensive overview of the roles of ncRNAs in ALD.
- To elucidate the mechanistic contributions of ncRNAs to ALD development and progression.
- To discuss the potential of ncRNAs as diagnostic biomarkers and therapeutic targets for ALD.
Main Methods:
- Literature review of studies investigating ncRNAs in alcohol-associated liver disease.
- Analysis of ncRNA involvement in key pathways such as hepatocyte injury, lipid metabolism, inflammation, and hepatic stellate cell activation.
- Examination of the role of extracellular vesicles in ncRNA-mediated intercellular communication in ALD.
Main Results:
- ncRNAs critically regulate gene expression and cellular functions relevant to liver health.
- Disrupted ncRNA expression in ALD exacerbates steatosis, inflammation, and fibrosis.
- Extracellular vesicles mediate ncRNA communication, amplifying liver damage and fibrosis in ALD.
Conclusions:
- ncRNAs play multifaceted roles in the pathogenesis and progression of ALD.
- ncRNAs represent promising diagnostic biomarkers for ALD.
- ncRNAs hold significant translational potential as therapeutic targets for ALD.
Keywords:
Alcohol-associated liver disease (ALD)BiomarkersCircular RNAs (circRNAs)Long non-coding RNAs (lncRNAs)MicroRNAs (miRNAs)Non-coding RNAs (ncRNAs)Therapeutic targetsMore Related Videos
Related Concept Videos
Cell Specific Gene Expression
14.0K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.0K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Types of RNA
65.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
65.3K
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K

